HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hogg, P. J. Articles by Jackson, C. M. Search for Related Content PubMed PubMed Citation Articles by Hogg, P. J. Articles by Jackson, C. M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 1, 248-255, 01, 1990

Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates

PJ Hogg and CM Jackson
American Red Cross Blood Services, Southeastern Michigan Region, Detroit, Michigan 48232.

The consequences of the combined effects of fibrin II monomer (FnIIm) and heparin (H) on the hydrolysis of peptidyl p-nitroanilide substrates by thrombin (IIa), the cleavage of prothrombin by thrombin and the thrombin-catalyzed release of fibrinopeptides from fibrinogen have been studied at pH 7.4 and I 0.15. The effects of fibrin II monomer and heparin on chromogenic substrate hydrolysis can be described by a hyperbolic mixed inhibition model in which substrate can interact with four possible enzyme species (IIa, IIa.H, IIa.FnIIm, and IIa.FnIIm.H) that arise as a result of random formation of a ternary complex among thrombin, fibrin II monomer, and heparin (Hogg, P. J. and Jackson, C. M. (1990) J. Biol. Chem. 265, 241-247). The formation of the ternary IIa.FnIIm.H complex results in an increase in the Km values of 7.03 +/- 1.17-fold (1.37-9.65 microM) and 1.94 +/- 0.60-fold (38.1-73.9 microM) for H-D-Ile-Pro-Arg-pNA and Cbz-Gly-Pro-Arg-pNA hydrolysis, respectively, and a decrease in the kc values of 0.45 +/- 0.08-fold (49.5-22.3 s-1) and 0.52 +/- 0.05-fold (93.1-48.4 s-1). Fibrin II monomer and heparin in combination also decrease the efficiency (kc/Km) with which thrombin cleaves prothrombin to produce Fragment 1 and Prethrombin 1 by 2.3-fold from 607 +/- 30 to 264 +/- 13 M-1 s-1. In contrast to the effects of fibrin II monomer and heparin on thrombin hydrolysis of chromogenic substrates, its proteolysis of prothrombin and its inactivation by antithrombin III (Hogg, P. J., and Jackson, C. M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3619-3623), these components have no discernible influence on the ability of thrombin to cleave fibrinogen. These observations indicate that the substrate specificity of thrombin is altered when it is bound in a complex with fibrin II monomer and heparin and suggest that the catalytic efficiency of thrombin for its physiological substrates will be affected differentially by these interactions. Such ternary complex formation involving thrombin, fibrin II monomer, and heparin may provide a mechanism for selectively regulating thrombin action.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. M. Verhamme, P. E. Bock, and C. M. Jackson The Preferred Pathway of Glycosaminoglycan-accelerated Inactivation of Thrombin by Heparin Cofactor II J. Biol. Chem., March 12, 2004; 279(11): 9785 - 9795. [Abstract] [Full Text] [PDF]

				I. Pechik, J. Madrazo, M. W. Mosesson, I. Hernandez, G. L. Gilliland, and L. Medved Crystal structure of the complex between thrombin and the central "E" region of fibrin PNAS, March 2, 2004; 101(9): 2718 - 2723. [Abstract] [Full Text] [PDF]

				C. H. Pospisil, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with Fibrin J. Biol. Chem., June 6, 2003; 278(24): 21584 - 21591. [Abstract] [Full Text] [PDF]

				I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798. [Abstract] [Full Text] [PDF]

				P.-E. Marque, R. Spuntarelli, L. Juliano, M. Aiach, and B. F. Le Bonniec The Role of Glu192 in the Allosteric Control of the S2' and S3' Subsites of Thrombin J. Biol. Chem., January 14, 2000; 275(2): 809 - 816. [Abstract] [Full Text] [PDF]

				D. L. Becker, J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II J. Biol. Chem., March 5, 1999; 274(10): 6226 - 6233. [Abstract] [Full Text] [PDF]

				S. M. Bates and J. I. Weitz Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin Cardiovasc Res, February 1, 1999; 41(2): 418 - 432. [Abstract] [Full Text] [PDF]

				P. J. Hogg, C. M. Jackson, J. K. Labanowski, and P. E. Bock Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen J. Biol. Chem., October 18, 1996; 271(42): 26088 - 26095. [Abstract] [Full Text] [PDF]

				J. S. Mruk, P. Zoldhelyi, M. W.I. Webster, M. Heras, D. E. Grill, D. R. Holmes Jr, V. Fuster, and J. H. Chesebro Does Antithrombotic Therapy Influence Residual Thrombus After Thrombolysis of Platelet-Rich Thrombus? : Effects of Recombinant Hirudin, Heparin, or Aspirin Circulation, February 15, 1995; 93(4): 792 - 799. [Abstract] [Full Text]

				P. C. Y. Liaw, D. L. Becker, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin J. Biol. Chem., June 8, 2001; 276(24): 20959 - 20965. [Abstract] [Full Text] [PDF]